Key value drivers CSL’s value creation cycle CSL’s people More than 32,000 people with diverse skills that drive the Company’s purpose and values Solutions for unmet needs Opportunities to improve and protect the quality of life of patients and communities in CSL’s therapeutic areas Business partners Accessing and sharing intellectual know-how to develop and innovate CSL products Natural resources Plasma donations for rare and serious diseases; influenza virus strains for vaccine manufacture; iron sources (including synthetic) for iron-based products; and environmental inputs such as water and energy Read more at csl.com/we‑are‑csl/corporategovernance/code‑of‑responsible‑business‑practice Read more at investors.csl.com/ investors/our-corporate-profile Value Creation Financial resources Cash, equity and debt for future growth Physical assets Plasma donation centres to collect vital raw material, manufacturing facilities for CSL products, warehouses, research and development facilities and offices for CSL’s people Early stage research & collaboration Product development & clinical trials Manufacturing & distribution Sales, marketing, policy advocacy & patient support Sourcing (including plasma collection) Pharmacovigilance OUR PURPOSE AND VALUES OUR STRATEGIC PILLARS CODE OF RESPONSIBLE BUSINESS PRACTICE OUR EXPERTISE AND OPERATIONS EFFICIENCY & RELIABLE SUPPLY DIGITAL TRANSFORMATION SUSTAINABLE GROWTH FOCUS INNOVATION 12 Limited Annual Report 2023/24
RkJQdWJsaXNoZXIy MjE2NDg3